BioLife Solutions Reports Third Quarter 2025 Financial Results
Provided By PR Newswire
Last update: Nov 6, 2025
Cell Processing revenue of $25.4 million, up 33% over Q3 2024
GAAP gross margin of 62% and non-GAAP adjusted gross margin of 64%
GAAP net income of $0.6 million and non-GAAP adjusted EBITDA of $7.8 million or 28% of revenue
Read more at prnewswire.com
